Your browser doesn't support javascript.
loading
Activated STAT3 may participate in tumor progression through increasing CD133/survivin expression in early stage of colon cancer.
Li, Wanlu; Lee, Mi-Ra; Kim, Taeyeong; Kim, Young Wan; Cho, Mee-Yon.
Afiliación
  • Li W; Department of Pathology, Yonsei University Wonju College of Medicine, Wonju, South Korea. Electronic address: lvvlchina@msn.cn.
  • Lee MR; Department of Pathology, Yonsei University Wonju College of Medicine, Wonju, South Korea. Electronic address: mira1125@yonsei.ac.kr.
  • Kim T; Department of Pathology, Yonsei University Wonju College of Medicine, Wonju, South Korea. Electronic address: wsckty@yonsei.ac.kr.
  • Kim YW; Division of Colorectal Surgery, Yonsei University Wonju College of Medicine, Wonju, South Korea. Electronic address: youngwkim@yonsei.ac.kr.
  • Cho MY; Department of Pathology, Yonsei University Wonju College of Medicine, Wonju, South Korea; Institute of Genomic Cohort, Yonsei University Wonju College of Medicine, Wonju, South Korea. Electronic address: meeyon@yonsei.ac.kr.
Biochem Biophys Res Commun ; 497(1): 354-361, 2018 02 26.
Article en En | MEDLINE | ID: mdl-29432737

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Colon / Factor de Transcripción STAT3 / Proteínas Inhibidoras de la Apoptosis / Carcinogénesis / Antígeno AC133 Límite: Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Colon / Factor de Transcripción STAT3 / Proteínas Inhibidoras de la Apoptosis / Carcinogénesis / Antígeno AC133 Límite: Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos